managing "molecule uncertainty"

Before making decisions on investment, capacity and supply to patients, boards and leadership teams like to be presented with options based on scenarios. We have been there many times before and know what it is like to make such decisions under uncertainty.  In our experience it is wise to develop sound scenarios backed by data.

Creating scenarios, however, is not always easy. So we are developing tools that are designed to be practical. We do not aim to compete on the size of our data sets or the complexity of our algorithms - we leave that to Google, Microsoft and others. Instead, we combine understandable models and intelligent inputs with user generated insights. Our tools allow you to intelligently manage the three elements of molecule uncertainty - phase risk, time and scale. As the decision maker, you can quickly get to the right direction. The areas that we cover are life cycle management, portfolio optimisation, risk management and scenario planning. Our target market is small and mid-sized pharma companies, CDMOs and related service companies. This is where much of the innovation stems from, yet we feel they are under-served with tools to support their growth. As healthcare companies scale-up, the trick is to retain the innovation and dynamism of the start-up with the necessary structure of larger companies that allows for global reach.